Cargando…
Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass
OBJECTIVE: The human acellular vessel (HAV) was evaluated for surgical bypass in a phase II study. The primary results at 24 months after implantation have been reported, and the patients will be evaluated for ≤10 years. METHODS: In the present report, we have described the 6-year results of a prosp...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976461/ https://www.ncbi.nlm.nih.gov/pubmed/36874956 http://dx.doi.org/10.1016/j.jvssci.2022.11.001 |